ALLIANCEBERNSTEIN L.P. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 188 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$27,192,000
+1074.1%
399,290
+450.7%
0.01%
+1200.0%
Q2 2022$2,316,000
-6.8%
72,500
+1.1%
0.00%0.0%
Q1 2022$2,484,000
+18.7%
71,702
+0.3%
0.00%0.0%
Q4 2021$2,093,000
+13.1%
71,502
-1.5%
0.00%0.0%
Q3 2021$1,850,000
-27.3%
72,6020.0%0.00%0.0%
Q2 2021$2,543,000
+128.3%
72,602
+165.6%
0.00%
Q1 2021$1,114,000
-31.7%
27,335
-27.4%
0.00%
-100.0%
Q4 2020$1,630,000
-21.8%
37,637
-0.4%
0.00%0.0%
Q3 2020$2,084,000
-25.3%
37,791
-14.5%
0.00%
-50.0%
Q2 2020$2,789,000
-57.3%
44,184
-65.5%
0.00%
-60.0%
Q1 2020$6,534,000
-35.2%
127,900
+0.9%
0.01%
-16.7%
Q4 2019$10,079,000
+154.9%
126,800
+55.6%
0.01%
+200.0%
Q3 2019$3,954,000
-7.8%
81,5000.0%0.00%
-33.3%
Q2 2019$4,287,000
+9.2%
81,500
+9.8%
0.00%0.0%
Q1 2019$3,927,000
+30.5%
74,200
+1.2%
0.00%
+50.0%
Q4 2018$3,009,000
+8.0%
73,3000.0%0.00%0.0%
Q3 2018$2,785,000
-14.9%
73,300
+1.2%
0.00%0.0%
Q2 2018$3,272,000
+22.0%
72,400
+30.5%
0.00%0.0%
Q1 2018$2,681,000
+23.4%
55,500
+0.5%
0.00%0.0%
Q4 2017$2,172,000
-7.0%
55,200
-26.6%
0.00%0.0%
Q3 2017$2,335,000
-58.4%
75,200
-63.4%
0.00%
-50.0%
Q2 2017$5,612,000
+542.8%
205,200
+765.8%
0.00%
+300.0%
Q1 2017$873,000
+111.9%
23,700
-16.8%
0.00%
Q4 2016$412,000
-37.3%
28,5000.0%0.00%
-100.0%
Q3 2016$657,000
+55.0%
28,500
+11.6%
0.00%
Q2 2016$424,000
-50.4%
25,546
-3.3%
0.00%
-100.0%
Q4 2015$854,000
+15.7%
26,416
+50.8%
0.00%0.0%
Q3 2015$738,00017,5160.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2018
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders